-
EP2421535
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2421535
| EP2421535 - HETEROAROMATIC AND AROMATIC PIPERAZINYL AZETIDINYL AMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 06.01.2017 Database last updated on 08.06.2024 | Most recent event Tooltip | 06.01.2017 | Application deemed to be withdrawn | published on 08.02.2017 [2017/06] | Applicant(s) | For all designated states Janssen Pharmaceutica N.V. Turnhoutseweg 30 2340 Beerse / BE | [2012/09] | Inventor(s) | 01 /
FLORES, Christopher, M. Janssen Research & Development LLC Welsh & McKean Rds. Spring House PA 19477 / US | 02 /
NELEN, Marina, I. 665 Stockton Drive Exton PA 19341 / US | 03 /
NULTON, Erica, L. 665 Stockton Drive Exton PA 19341 / US | 04 /
PROUTY, Stephen 3900 Woodland Avenue Bldg. 21 Room 302A Philadelphia PA 19104 / US | 05 /
TODD, Matthew 665 Stockton Drive Exton PA 19341 / US | 06 /
ZHANG, Sui-Po 665 Stockton Drive Exton PA 19341 / US | [2012/17] |
| Former [2012/09] | 01 /
FLORES, Christopher, M. Welsh&McKean Roads Spring House PA 19477 / US | ||
| 02 /
NELEN, Marina, I. 665 Stockton Drive Exton PA 19341 / US | |||
| 03 /
NULTON, Erica, L. 665 Stockton Drive Exton PA 19341 / US | |||
| 04 /
PROUTY, Stephen 3900 Woodland Avenue Bldg. 21 Room 302A Philadelphia PA 19104 / US | |||
| 05 /
TODD, Matthew 665 Stockton Drive Exton PA 19341 / US | |||
| 06 /
ZHANG, Sui-Po 665 Stockton Drive Exton PA 19341 / US | Representative(s) | Warner, James Alexander, et al Carpmaels & Ransford LLP One Southampton Row London WC1B 5HA / GB | [N/P] |
| Former [2012/09] | Warner, James Alexander, et al Carpmaels & Ransford One Southampton Row London WC1B 5HA / GB | Application number, filing date | 10714829.8 | 22.04.2010 | WO2010US32100 | Priority number, date | US20090171661P | 22.04.2009 Original published format: US 171661 P | [2012/09] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2010124122 | Date: | 28.10.2010 | Language: | EN | [2010/43] | Type: | A1 Application with search report | No.: | EP2421535 | Date: | 29.02.2012 | Language: | EN | The application published by WIPO in one of the EPO official languages on 28.10.2010 takes the place of the publication of the European patent application. | [2012/09] | Search report(s) | International search report - published on: | EP | 28.10.2010 | Classification | IPC: | A61K31/496, A61P29/00, A61P25/02, A61P1/06 | [2012/09] | CPC: |
A61K31/496 (EP,KR);
A61K31/497 (KR);
A61K47/30 (KR);
A61K9/0053 (KR);
A61P1/04 (EP);
A61P1/06 (EP);
A61P25/00 (EP);
A61P25/02 (EP);
A61P25/04 (EP);
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR [2012/09] | Extension states | AL | 18.11.2011 | BA | 18.11.2011 | ME | 18.11.2011 | RS | 18.11.2011 | Title | German: | HETEROAROMATISCHE UND AROMATISCHE PIPERAZINYL-AZETIDINYL-AMIDE ALS MONOACYLGLYCEROL-LIPASE-INHIBITOREN | [2012/09] | English: | HETEROAROMATIC AND AROMATIC PIPERAZINYL AZETIDINYL AMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS | [2012/09] | French: | PIPÉRAZINYL AZÉTIDINYL AMIDES HÉTÉROAROMATIQUES ET AROMATIQUES EN TANT QU'INHIBITEURS DE LA MONOACYLGLYCÉROL LIPASE | [2012/09] | Entry into regional phase | 18.11.2011 | National basic fee paid | 18.11.2011 | Designation fee(s) paid | 18.11.2011 | Examination fee paid | Examination procedure | 18.11.2011 | Examination requested [2012/09] | 11.06.2012 | Amendment by applicant (claims and/or description) | 07.04.2016 | Communication of intention to grant the patent | 18.08.2016 | Application deemed to be withdrawn, date of legal effect [2017/06] | 23.09.2016 | Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time [2017/06] | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 07.04.2016 | Fees paid | Renewal fee | 28.03.2012 | Renewal fee patent year 03 | 12.04.2013 | Renewal fee patent year 04 | 25.03.2014 | Renewal fee patent year 05 | 10.04.2015 | Renewal fee patent year 06 | 11.04.2016 | Renewal fee patent year 07 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [A]FR2915199 (SANOFI AVENTIS SA [FR]) [A] 1-15 * table 1 * * page 8 - page 9 * * page 11, line 28 - page 13, line 8 ** claims 9,11 *; | [E]EP2180048 (JANSSEN PHARMACEUTICA NV [BE]) [E] 1-15 * claim 4; compound 2 * * claims 1,4 * * page 2, paragraph 0005 - paragraph 0007 * * page 11, paragraph 0119 * | by applicant | - PERTWEE, BRIT JPHARMACOL, (2008), vol. 153, pages 199 - 215 | - MATSUDA ET AL., NATURE, (1990), vol. 346, pages 561 - 4 | - MUNRO ET AL., NATURE, (1993), vol. 365, pages 61 - 5 | - DI MARZO ET AL., CURR OPIN LIPIDOL, (2007), vol. 18, pages 129 - 140 | - PACHER ET AL., AMER JPHYSIOL, (2008), vol. 294, pages H1133 - H1134 | - BENITO ET AL., BRIT J PHARMACOL, (2008), vol. 153, pages 277 - 285 | - CAVUOTO ET AL., BIOCHEM BIOPHYS RES COMMUN, (2007), vol. 364, pages 105 - 110 | - HAJRASOULIHA ET AL., EUR J PHARMACOL, (2008), vol. 579, pages 246 - 252 | - CRAVATT ET AL., JNEUROBIOL, (2004), vol. 61, pages 149 - 60 | - GUINDON ET AL., BRIT JPHARMACOL, (2008), vol. 153, pages 319 - 334 | - DEVANE ET AL., SCIENCE, (1992), vol. 258, pages 1946 - 9 | - MECHOULAM ET AL., BIOCHEM PHARMACOL, (1995), vol. 50, pages 83 - 90 | - SUGIURA ET AL., BIOCHEM BIOPHYS RES COMMUN, (1995), vol. 215, pages 89 - 97 | - PIOMELLI, NAT REV NEUROSCI, (2003), vol. 4, pages 873 - 884 | - LICHTMAN ET AL., PAIN, (2004), vol. 109, pages 319 - 27 | - KATHURIA ET AL., NAT MED, (2003), vol. 9, pages 76 - 81 | - WALKER ET AL., PROC NATL ACAD SCI USA, (1999), vol. 96, pages 12198 - 203 | - DOGRUL ET AL., PAIN, (2002), vol. 100, pages 203 - 9 | - LICHTMAN ET AL., JPHARMACOL EXP THER, (2002), vol. 302, pages 73 - 9 | - SHABAT ET AL., EUR J PHARMACOL, (1998), vol. 353, pages 23 - 31 | - COMELLI ET AL., BRIT JPHARMACOL, (2007), vol. 152, pages 787 - 794 | - DI MARZO ET AL., CURR PHARM DES, (2000), vol. 6, pages 1361 - 80 | - JHAVERI ET AL., BRIT J PHARMACOL, (2007), vol. 152, pages 624 - 632 | - MCCARBERG BILL ET AL., AMER J THER, (2007), vol. 14, pages 475 - 83 | - NJIE, YA FATOU; HE, FANG; QIAO, XHUANHONG; SONG, ZHOA-HUI, EXP. EYE RES., (2008), vol. 87, no. 2, pages 106 - 14 | - PANTOLIANO, M. W.; PETRELLA, E. C.; KWASNOSKI, J. D.; LOBANOV, V. S.; MYSLIK, J.; GRAF, E.; CARVER, T.; ASEL, E.; SPRINGER, B. A.;, J BIOMOL SCREEN, (2001), vol. 6, pages 429 - 40 | - MATULIS, D.; KRANZ, J. K.; SALEMME, F. R.; TODD, M. J., BIOCHEMISTRY, (2005), vol. 44, pages 5258 - 66 | - PANTOLIANO, M. W.; PETRELLA, E. C.; KWASNOSKI, J. D.; LOBANOV, V. S.; MYSLIK, J.; GRAF, E.; CARVER, T.; ASEL, E.; SPRINGER, B. A.;, JBIOMOL SCREEN, (2001), vol. 6, pages 429 - 40 |